Literature DB >> 7351050

Myocardial lactate extraction: multi-determined metabolic function.

E W Gertz, J A Wisneski, R Neese, A Houser, R Korte, J D Bristow.   

Abstract

Myocardial lactate production indicates anaerobic metabolism resulting from hypoxia or anoxia. Clinically, myocardial lactate extraction of less than 10% has also been used as an indicator of ischemia. Sixteen healthy young male volunteers underwent coronary sinus and aterial catheterization. A coronary sinus pacing catheter was used to obtain blood samples and increase the heart rate to twice the resting rate. Hemodynamic measurements and blood samples for lactate, free fatty acids and glucose were obtained at rest and during pacing. Seven of 16 sujects (44%) had lactate extraction of less than 10% at rest and/or at miximal pacing. No subject produced lactate. There was no correlation between myocardial lactate extraction and arterial glucose. However, lactate extraction correlated inversely with the arterial levels of free fatty acids (r = 0.67; p less than 0.01). In addition, a positive correlation was present between lactate extraction and the arterial lactate level (r = 0.78; p less than 0.01). In conclusion, myocardial lactate extraction is dependent on multiple metabolic parameters and any absolute value short of production cannot be considered abnormal.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351050     DOI: 10.1161/01.cir.61.2.256

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.

Authors:  William C Stanley; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

2.  Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments.

Authors:  E W Gertz; J A Wisneski; W C Stanley; R A Neese
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.

Authors:  K Chatterjee; J L Rouleau; W W Parmley
Journal:  Br Heart J       Date:  1982-03

4.  Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; G M Rosano; J S Gill; P A Poole-Wilson; J C Kaski; W J McKenna
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

5.  Differential effects of defibrillation on systemic and cardiac sympathetic activity.

Authors:  F Bode; U Wiegand; W Raasch; G Richardt; J Potratz
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

6.  Myocardial and skeletal muscle glucose uptake during exercise in humans.

Authors:  Jukka Kemppainen; Toshihiko Fujimoto; Kari K Kalliokoski; Tapio Viljanen; Pirjo Nuutila; Juhani Knuuti
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

7.  Involvement of ATP-sensitive potassium channels in preconditioning protection.

Authors:  S Rohmann; H Weygandt; P Schelling; L Kie Soei; P D Verdouw; I Lues
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

8.  Milrinone in heart failure. Acute effects on left ventricular systolic function and myocardial metabolism.

Authors:  A D Timmis; P Smyth; M Monaghan; L Walker; K Daly; A A McLeod; D E Jewitt
Journal:  Br Heart J       Date:  1985-07

9.  Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action.

Authors:  C Mannheimer; T Eliasson; B Andersson; C H Bergh; L E Augustinsson; H Emanuelsson; F Waagstein
Journal:  BMJ       Date:  1993-08-21

10.  Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.

Authors:  J A Wisneski; E W Gertz; R A Neese; M Mayr
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.